Skip to main content
Fig. 11 | Journal of Neuroinflammation

Fig. 11

From: MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 2: Epidemiology, clinical presentation, radiological and laboratory features, treatment responses, and long-term outcome

Fig. 11

Outcome after acute attacks in MOG-IgG-positive patients compared with a previously published AQP4-IgG-positive cohort. a Outcome after acute myelitis in MOG-IgG-positive (46 evaluable attacks) and in AQP4-IgG-positive patients (298 evaluable attacks [34]). b Outcome after acute ON in MOG-IgG-positive (134 evaluable attacks) and in AQP4-IgG-positive patients (205 evaluable attacks; see ref. [34]). Note that ‘complete recovery’ includes ‘almost complete recovery’ in the left graph (no such distinction was made in the AQP4-IgG-positive cohort)

Back to article page